Skip to content
10-Q

Quarterly Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-21-009463

← back to feed
Filed
Apr 22, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Apr 22, 2021 160.74M sh
Cash And Equivalents Q2 2020 · Jun 30, 2020 $41.17K
Cash And Equivalents Q2 2020 · Dec 31, 2019 $14.83K
Stockholders Equity Q2 2020 · Jun 30, 2020 $789.57K
Stockholders Equity Q2 2020 · Dec 31, 2019 $1.59M
Current Liabilities Q2 2020 · Jun 30, 2020 $3.02M
Current Liabilities Q2 2020 · Dec 31, 2019 $2.19M
Total Liabilities Q2 2020 · Jun 30, 2020 $3.84M
Total Liabilities Q2 2020 · Dec 31, 2019 $2.88M
Current Assets Q2 2020 · Jun 30, 2020 $818.79K
Current Assets Q2 2020 · Dec 31, 2019 $604.43K
Total Assets Q2 2020 · Jun 30, 2020 $4.63M
Total Assets Q2 2020 · Dec 31, 2019 $4.47M
Stock Issued Q2 2020 · Apr 30, 2020 384.62K sh
Stock Issued Q2 2020 · Mar 31, 2020 1.54M sh
Capex restated Q2 2020 · Jun 30, 2019 $1.04M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$1.94M
Net Income Q2 2020 · Jun 30, 2019 −$555.6K
Net Income Q2 2020 · Jun 30, 2019 −$1.84M
Net Income Q2 2020 · Mar 31, 2019 −$1.29M
Operating Income Q2 2020 · Jun 30, 2019 −$534.1K
Operating Income Q2 2020 · Jun 30, 2019 −$1.53M
Gross Profit Q2 2020 · Jun 30, 2019 $559.88K
Gross Profit Q2 2020 · Jun 30, 2019 $649.11K
Revenue Q2 2020 · Jun 30, 2019 $718.44K
Revenue Q2 2020 · Jun 30, 2019 $1.44M